IQV News and Press, IQVIA Holdings Inc. From 01/24/24

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2023 financial results before the market opens on Wednesday, February 14, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. ...

2024-01-24 08:54:54 ET More on Biogen, Eisai Co., Ltd., etc. Biogen Inc. (BIIB) JPMorgan 42nd Annual Healthcare Conference (Transcript) Biogen: LEQEMBI's $10 Billion Potential Biogen Inc. (BIIB) Evercore ISI 6th Annual HealthCONx Conference (Transcript) Eisai...

2024-01-24 01:35:00 ET Summary Cedar Creek Partners is a private investment partnership that focuses primarily on micro and small cap equities. Cedar Creek Partners is managed by Eriksen Capital Management LLC, a registered investment adviser. Cedar Creek increased by 2.8% in the ...

Growth outlook is raised by 2 percentage points despite lower expectations for COVID-19 vaccines and therapeutics This increase in growth outlook is driven by more patients getting treated with better medicines, especially in immunology, endocrinology, and oncology Medicine use in Latin A...

2024-01-16 13:53:50 ET More on IQVIA: IQVIA Q3: TAS Segment Remains The Problem Child IQVIA: I Would Stay Away Until Debt Issues Are Resolved IQVIA Holdings, Inc. (IQV) Q3 2023 Earnings Call Transcript U.S. judge upholds FTC bid to block Iqvia’s DeepIn...

2024-01-16 07:10:45 ET More on ANI Pharmaceuticals ANI Pharmaceuticals: A New Assessment ANI Pharmaceuticals, Inc. (ANIP) Q3 2023 Earnings Call Transcript 3 Catalysts Could Drive ANI Pharmaceuticals' PPS Growth Through November 2023 ANI Pharmaceuticals Non-GA...

2024-01-09 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-08 10:52:52 ET Summary Veeva's revenue growth has slowed over the past two years and is expected to continue to slow in FY24. Uncertainties surrounding product adoption, platform migration, and competition pose risks to Veeva's future growth. Veeva's valuation is consi...

2024-01-04 13:30:03 ET Truist Financial analyst issues BUY recommendation for IQV on January 4, 2024 02:00PM ET. The previous analyst recommendation was Buy. IQV was trading at $220.06 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...

2024-01-02 15:13:41 ET More on IQVIA IQVIA Q3: TAS Segment Remains The Problem Child IQVIA: I Would Stay Away Until Debt Issues Are Resolved IQVIA Holdings, Inc. (IQV) Q3 2023 Earnings Call Transcript Iqvia launches notes offering, enters into new term loan a...